To evaluate the incidence of MACE-4 events in patients treated with tirzepatide compared to the control group, a meta-analysis was conducted using data from 7778 patients enrolled in the SURPASS-4 study, SURPASS Clinical Trails Program (which includes 7 randomized clinical trials), and SURMOUNT-1
Where the Field Is Heading The retatrutide weight loss readout has set a new published Phase 3 ceiling for the GLP-1-class category
Self-pay is also an option
Dvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, et al
NAD+ Intramuscular (IM) Shots help accelerate the healing of muscles, tissues and cells in just 5 minutes
This process is often accompanied by changes in a series of key regulatory molecules of ferroptosis